Dr. Scott M Rocklage is an inspirational medical professional with over 30 years of experience in the healthcare field.Mr. Rocklage works for 5 AM Ventures as a managing partner. The company is a scientifically based venture capital company. The pharmaceutical specialist joined the company in 2003 as a Venture Partner, and he joined his current role in 2004.
Scott Rocklage wears many hats in the healthcare sector they include a chairman role in the Rennovia, Cidara Therapeutics, Epirus, Kinestral and Pulmatrix boards. Read more; Scott Racklage | Bloomberg and Scott Racklage | Crunchbase
Before the roles above, Dr. Rocklage also served as the Cubist Pharmaceuticals CEO and Chairman, The Nycomed Salutar CEO and President, Salutar, and Catalytica under numerous R&D positions. In addition to this, he has also been at Relypsa as a Board Chairman, and Novira, Ilypsa Executive chairman, Semprus, and Miikana. Johnson & Johnson presently own Novira. Ilypsa was bought out by Amgen, Semprus was purchased out by Teleflex and Miikana is currently EntreMed.
Dr. Scott Rocklage And 5 Am Ventures:
5 AM Ventures is a venture capital company that deals with enterprises that are interested in life science.
The firm works with companies that are constantly trying to scientifically research new medicines and come up with medical advancements for various diseases. The company is named after the timing it exudes in dealing with healthcare advancements.
Dr. Rocklage’s role in the healthcare company is to liaise with the company’s management portfolio team, researching new angles of life sciences, to attend and prepare for meetings with the board among many other roles.
Due to his position in this company, Dr. Rocklage liaises with various industrialists in the life science industry they include scientists, business executives, and physicians. It is these people’s ideas that assist in coming up with promising drugs that meet the challenging need of getting new medicines which may treat new diseases like Cancer.
Scott Rocklage successfully runs 5 AM Ventures with a hands on approach. So far he has been able to determine the best companies to invest in.
5 AM employs people who have all types of backgrounds which include finance, science, law, medicine, and business operations. This blend of employees is responsible for the smooth running of the venture capital firm.
The company initially provides the companies they invest in with capital. In addition to this, it also plays the role of an operation manager, board member, brief management, and business strategist among many others.
Dr. Scott M. Rocklage attended the University of California, Berkeley for a Bachelor of Science Degree in Chemistry. Rocklage also attended Massachusetts Institute of Technology for a Ph.D. in Chemistry.
While studying here, he researched the Nobel Prize Laureate Richard r. Schrock in his laboratory.